Income statement
CAD
Annual
| Metric | 2025 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 5M | 3M | 595K | 0 | 0 |
| Gross Profit | 195K | 3M | -335K | -16K | 0 |
| Operating Income | -1M | -725K | -6M | -4M | -253K |
| EBITDA | -278K | -422K | -5M | -4M | -253K |
| Net Income | -2M | -718K | -6M | -4M | -253K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.62
+0.68% today
Window Change
+37.78%
Window
May 29, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars · May 29, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Telescope Innovations Corp. (TELIF) is a Healthcare stock with a market cap of $30.00M and listed on OTC. The stock last traded around $0.62 and up 37.8% across the available one-year price window (May 29, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin -52.2% and ROIC -49.4%. Valuation is more restrained than many high-expectation growth names at price/sales 3.7. Stock Foundry combines TELIF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TELIF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TELIF Max Drawdown
-17.45%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TELIF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$253.0K
+93.7% YoY
Free Cash Flow
-$718.0
+100.0% YoY
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
1.8%
Net Margin
-44.8%
Income statement
CAD
| Metric | 2025 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 5M | 3M | 595K | 0 | 0 |
| Gross Profit | 195K | 3M | -335K | -16K | 0 |
| Operating Income | -1M | -725K | -6M | -4M | -253K |
| EBITDA | -278K | -422K | -5M | -4M | -253K |
| Net Income | -2M | -718K | -6M | -4M | -253K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3M | 357K | 719K | 3M | 3K |
| Total Assets | 7M | 3M | 3M | 4M | 10K |
| Total Liabilities | 5M | 713K | 1M | 247K | 109K |
| Shareholder Equity | 2M | 3M | 2M | 4M | -99K |
| Total Debt | 2M | 0 | 0 | 0 | 22K |
| Net Debt | 2M | -357K | -719K | -3M | 19K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
718
+99.9% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
718
+100.0% YoY
Key ratios
Gross Margin
1.8%
Operating Margin
-52.2%
Net Margin
-44.8%
ROE
-99.3%
Debt / Equity
0.58x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.